disclosed are methods , protocols , and compositions of matter useful for generation of lymphocytes with permanently inactivated immunological checkpoint genes , said genes comprising pd - 1 , ctla - 4 , lag - 3 , and tim - 3 . the generated lymphocytes may be autologous or allogeneic , and are useful in the treatment of neoplastic , viral or bacterial infections .